Amphastar Pharmaceuticals (29A.F) Q1 2025 Earnings

27FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
0.71
0.79
0.88
0.97

Details

Expected EPS
0.9022692800000001
Actual EPS
0.884672
Surprise EPS
-0.02
Surprise Percent
+1.95%

Description

Amphastar Pharmaceuticals (29A.F) has reported earnings of 0.884672 per share for Q1 2025.

0 Comments

Share your thoughts